Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Head and Neck Neoplasms 43Thyroid Neoplasms 18Thyroid Nodule 7Squamous Cell Carcinoma of Head and Neck 7Mouth Neoplasms 7Lung Neoplasms 6Thyroid Diseases 5Neoplasm Metastasis 5Goiter 5Pain, Postoperative 4Nasopharyngeal Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Renal Cell 4Breast Neoplasms 4Parathyroid Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mucositis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Xerostomia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Thyroid Cancer, Papillary 2Stomatitis 2Stomach Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Nausea × Head & Neck × Clear all
NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Mt. Sinai Medical Center, Miami

Phase 4 Completed
452 enrolled
Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡